No insider purchase over the last 90 days. The latest, by 杨瑾, was filed 28 Dec 2023.
Shaanxi Kanghui Pharmaceutical Co., Ltd.: what insiders have been doing
Shaanxi Kanghui Pharmaceutical Co., Ltd. has a thin disclosure history in our data (latest filing: 28 December 2023). New filings will appear here as soon as they are published. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Top signal score 15 of 100
Buys €94,479n/a Sells
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 23,900 of 26,248 companies
20.6
score / 100
Value
25
Quality
16
FCF yld-0.9%
Earn yld-9.4%
EV/EBITDA·
ROE-37%
Gross mgn25%
Net mgn-71%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
40,000 shares100.0% of flowA股XSHGSSE:173000007192662880
Canonical exit: 27 Mar 2024 (T+90)
1 of 1 declaration
About Shaanxi Kanghui Pharmaceutical Co., Ltd.
康惠股份 is a company in the agro-food sector, listed on the Shanghai Stock Exchange (XSHG). It specializes in the production and distribution of food products.